Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma

This is a phase 2, multicentre, open-label, randomised, controlled trial with a parallel-group design. The study aims to evaluate the efficacy and safety of single-agent Becotatug Vedotin as adjuvant therapy in patients with high-risk locoregionally advanced nasopharyngeal carcinoma (NPC).

Participants needed: 140
Trial details
Phase: Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Kai HuUpdated: Jun 9, 2026Locations: 1
Eligibility criteria

Histologically confirmed non-keratinizing nasopharyngeal carcinoma(WHO II/III). [+7]

Patients who could not tolerate or were allergic to Becotatug Vedotin. [+6]

Read more
Status: Recruiting

A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

A Clinical Study to Investigate the Safety, Efficacy, and Cellular Metabolism of CT1190B CAR-T Cell therapy, in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma.

Participants needed: 24
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Kai HuUpdated: Feb 12, 2025Locations: 1
Eligibility criteria

Participants must voluntarily sign the informed consent form (ICF) and must be w... [+8]

Pregnant or lactating women; [+12]

Read more